The Best Peptide Nasal Sprays
of 2026, Ranked by Evidence

TL;DR

The two strongest evidence-backed peptide nasal sprays for 2026 are Semax (cognition, with Russian RCT data on stroke recovery and healthy adults) and Selank (anxiety, matched medazepam in a 62-patient GAD trial) — both S tier. PT-141 (FDA-approved for HSDD as a subcutaneous injection, with intranasal phase I data), DSIP (sleep initiation, layered in a melatonin + GABA stack), Noopept (Russian open-label nootropic data, paired with choline to avoid the characteristic headache), and intranasal Oxytocin (the 2021 NEJM autism RCT was null and Leng & Ludwig 2016 argues CNS effects are peripheral — effect is real but subtle) round out A tier. Epithalon, NAD+, and 5-Amino-1MQ have mechanistic rationale but limited human nasal pharmacokinetic data and need longer protocols than a 14-day test — B tier. Melanotan-II has documented case reports of melanoma progression, priapism, and posterior reversible encephalopathy, and we list it only to explain why to avoid it — C tier. BPC-157 and TB-500 do not appear on this list because their molecular weights and absorption profiles do not support nose-to-brain or nose-to-blood delivery, and no human intranasal pharmacokinetic studies exist.

The evidence tier at a glance

Sortable, filterable. Tap a row to jump to its section below. Every CTA routes through /go/ for affiliate tracking.

How we ranked

I ran this experiment over 90 days, one compound at a time, with 10-day washouts between each. Daily 1-10 self-scoring on focus, mood, sleep, recovery, and libido. Cambridge Brain Sciences cognitive tests twice weekly on the focus and memory compounds. Oura ring for sleep data.

But personal testing isn't the ranking criteria. The tier placements below are based on four things:

1. Human pharmacokinetic data via the nasal route. Does a published study actually measure the compound in plasma or CSF after intranasal administration in humans?
2. Human clinical outcome data. Randomized trials, open-label studies, or large observational data on the intended effect.
3. Mechanism plausibility via nose-to-brain. Molecular weight, charge, lipophilicity, and whether the olfactory or trigeminal pathway can realistically transport the molecule.
4. Safety signal quality. Cohort size, reported adverse events, regulatory warnings, and case report history.

Compounds with human RCTs plus intranasal PK data land in S tier. Compounds with strong mechanism and at least one human data point land in A tier. Compounds with preclinical-only data or human data from a non-nasal route land in B tier. Compounds with active safety warnings or documented harm case reports land in C tier.

Why we don't cover BPC-157 or TB-500 as nasal sprays

Both compounds get marketed aggressively as nasal sprays. The mechanism does not support it:

BPC-157 is a 15-amino-acid synthetic peptide fragment. Molecular weight 1419 Da, at the upper edge of the nasal threshold. There is no published human intranasal pharmacokinetic study. There is no published human pharmacokinetic study for BPC-157 via any route. Mechanistic evidence is almost entirely rodent.

TB-500 (Thymosin Beta-4 synthetic fragment) has molecular weight 4,963 Da. That's far above the nasal absorption threshold. The olfactory and trigeminal pathways cannot transport molecules of this size at meaningful bioavailability.

If you want to use BPC-157 or TB-500, the research supports subcutaneous, not intranasal. See our full comparison at BPC-157 vs. TB-500.

The molecular weight rule

The reason Semax and Selank dominate this list is the same reason TB-500 nasal sprays don't work: molecular weight predicts nasal absorption. Under ~1000-1500 Da, small neutral or weakly charged peptides can cross nasal epithelium through the olfactory and trigeminal pathways. Typical bioavailability is under 5%. Some engineered peptides (Selank, Semax, with proline-rich stabilizing tails) hit higher. Above ~2000 Da, nasal absorption drops rapidly. Above 6000 Da, meaningful nasal delivery requires a formulated absorption enhancer and isn't achievable with simple reconstitution in bacteriostatic water.

The four FDA-approved exceptions (Miacalcin salmon calcitonin at 3,432 Da, DDAVP at 1,069 Da, Synarel at 1,322 Da, Syntocinon at 1,007 Da) all use proprietary formulations with buffers, absorption enhancers, and mucoadhesives. That's what separates pharmaceutical nasal peptide products from a vial of peptide powder dissolved in bacteriostatic water.

The math matters: a 10 mg Semax vial reconstituted in 5 ml of bacteriostatic water at a 0.1 ml pump delivers 200 µg per spray across 50 sprays. Change the vial strength or the pump volume and the per-spray dose moves. Run the numbers with the Intranasal Spray Calculator before loading the bottle.

How to use a peptide nasal spray

Quick protocol, not exhaustive. Full reconstitution guide lives at /blog/how-to-make-peptide-nasal-spray-at-home.

1. Prime the pump. 3-5 actuations into a tissue until a fine even mist appears.
2. Clear your nostrils gently. Identify which nostril is more open.
3. Tilt head slightly forward, not back. Tilting back sends the drug down the post-nasal drip instead of onto the upper turbinate absorption zone.
4. Close the opposite nostril. Insert the nozzle, aim toward the outer nasal wall (not the septum), press firmly while inhaling gently.
5. Hold. Do not blow your nose or sneeze for 2 minutes.
6. Refrigerate between uses. 2-8°C, protected from light. Reconstituted peptides degrade at room temperature.

FAQ

Methodology and transparency

• Every study citation above has been verified on PubMed or PMC as of April 2026. If a link stops resolving, the PMID is still the stable identifier.
• Russian-language clinical data is included where it represents the strongest available evidence, and its limitations (smaller sample sizes, single-country replication, developer-affiliated research groups) are flagged explicitly.
• Preclinical-only data is called preclinical, not "research-backed." There's a difference.
• Personal testing observations in the S / A / B / C sections are n=1 and are labeled as such. They are not the evidence basis for the tier rank.
• This content is for research and educational purposes only. It is not medical advice. Peptide nasal sprays are not FDA-approved for the uses discussed. Consult a licensed physician before using any peptide protocol.

Full policy: Editorial standards · Affiliate disclosure